SEC Form 4 · accession 0001140361-26-026930
Vericel Corp · VCEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Mark Hopper
Officer — Chief Medical Officer
Period of report
Jun 26, 2026
Accepted (ET)
Jun 30, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000887359
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 26, 2026 | M | 5,000 | $29.82 | A | 80,753 | D | |
| Common StockF2,F1 | Jun 26, 2026 | S | 5,000 | $45.00 | D | 75,753 | D | |
| Common StockF1 | Jun 26, 2026 | M | 5,000 | $29.82 | A | 80,753 | D | |
| Common StockF2,F1 | Jun 26, 2026 | S | 5,000 | $45.00 | D | 75,753 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $29.82 | Jun 26, 2026 | M | 5,000 | A | — | Feb 17, 2033 | Common Stock | 5,000 | 25,000 | D |
| Stock Option (Right to Buy)F3 | $29.82 | Jun 26, 2026 | M | 5,000 | A | — | Feb 17, 2033 | Common Stock | 5,000 | 20,000 | D |
Explanation of responses
- F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
- F3These options, representing the right to purchase 30,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.